Aldeyra Shares Fall on FDA Complete Response Letter for Dry Eye Disease Drug
Aldeyra Therapeutics shares fell 73% to $1.42 in the regular session after it reported a Food and Drug Administration complete response letter for reproxalap for treatment of dry eye disease. The ...
Stocktwits on MSN10h
Aldeyra Stock Slumps After FDA Says Investigational Drug For Dry Eyes Treatment Failed To Demonstrate Efficacy – Retail Stays Optimistic
Shares of Aldeyra Therapeutics, Inc. (ALDX) slumped nearly 71% on Thursday morning after it said that the U.S. Food and Drug ...
I Have Chronically Dry Eyes And This Is The $29 Product That My Doctor Recommended
The Aroma Season eye mask is filled with natural flax seeds to offer a slightly compressive, non-toxic remedy and a design ...
The Best Grocery Deals You Can Find on Amazon Pantry
Stock up with Amazon Pantry and watch the savings add up. What is Amazon Pantry? Amazon Prime Pantry (also known as Amazon ...